Biopharmaceutical Excipients Market Forecast Reveals Where Future Industry Value Will Be Created
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Biopharmaceutical Excipients Market Growth From $3.57 Billion In 2026 To $5.03 Billion By 2030 At A CAGR Of 9%
The biopharmaceutical excipients sector has experienced robust expansion over the past few years. Its market valuation is projected to rise from $3.27 billion in 2025 to $3.57 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.2%. This historic growth has been driven by factors including a higher number of biologic drug approvals, the early implementation of protein stabilizers, the increasing use of injectable formulations, the growth of vaccine development efforts, and improvements in formulation science.
The biopharmaceutical excipients market is projected to experience robust expansion over the coming years, reaching a value of $5.04 billion by 2030, with a compound annual growth rate (CAGR) of 9.0%. This anticipated growth during the forecast period is driven by factors such as the heightened complexity of biologic formulations, a growing need for products with extended shelf lives, the expansion of cell and gene therapies, stricter regulatory scrutiny regarding excipient safety, and increased investments in sophisticated drug delivery systems. Key trends shaping the market include a rising preference for high-purity biologic excipients, broader adoption of multifunctional ingredients in formulations, the development of excipients specifically designed for cell and gene therapies, a greater emphasis on compounds that enhance stability, and more tailored excipient solutions to meet specific requirements.
Download A Free Sample Report For Comprehensive Market Insights:
Biopharmaceutical Excipients Market Expansion Drivers: What Is Shaping Future Growth?
The rising need for vaccine development is anticipated to fuel expansion in the biopharmaceutical excipients market moving forward. Vaccine development involves the creation and formulation of immunizations designed to prevent infectious diseases and enhance public health, depending on premium excipients to maintain the stability, effectiveness, and safety of vaccine products. This increasing demand is driven by a global emphasis on combating infectious diseases, bolstering public health readiness, and accelerating research to provide quicker and more efficient immunization options. Biopharmaceutical excipients are essential in vaccine formulations, as they stabilize antigens, improve solubility, and preserve product integrity during storage and transport. For example, in 2025, the Centers for Disease Control and Prevention, a US national public health agency, reported that adolescent vaccination coverage for key vaccines like tetanus, diphtheria, and acellular pertussis climbed from 89.9% in 2022 to 91.3% in 2024, meningococcal conjugate vaccine coverage increased from 88.6% to 90.1%, and human papillomavirus vaccine coverage (with two or more doses) rose markedly from 76.0% to 92.6% during the same timeframe. Consequently, the growing demand for vaccine development is propelling the biopharmaceutical excipients market forward.
Biopharmaceutical Excipients Market Segment Outlook: Which Categories Are Expanding The Fastest?
The biopharmaceutical excipients market covered in this report is segmented –
1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents
2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics
3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives
4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy
5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes
Subsegments:
1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders
2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings
3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol
4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate
5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide
6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol
7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols
8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate
9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers
Biopharmaceutical Excipients Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Major players in the biopharmaceutical excipients industry are prioritizing technological advancements, particularly the development of ultra-high purity surfactants, to enhance protein stability, minimize degradation, and ensure adherence to regulatory standards in injectable formulations. These surfactants are meticulously processed active agents characterized by extremely low impurity levels and uniform composition, guaranteeing stability, safety, and optimal performance in delicate pharmaceutical and biopharmaceutical products. For example, in September 2025, Evonik Industries AG, a chemical company based in Germany, unveiled MaxiPure Polysorbate 80 tailored for injectable and biopharmaceutical uses. This excipient boasts an oleic acid content exceeding ninety-eight percent, outstanding clarity, and complete alignment with European, United States, Japanese, and Chinese pharmacopoeial requirements. It effectively tackles key obstacles related to protein stability, curbs oxidative degradation, provides consistent solubilization for hydrophobic active ingredients, and bolsters formulation dependability. By incorporating this excipient, Evonik assists pharmaceutical and biopharmaceutical firms in effectively creating intricate biologics and injectable treatments while maintaining compliance and efficacy.
Biopharmaceutical Excipients Market Key Companies And Competitive Benchmarking
Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.
Access The Complete Biopharmaceutical Excipients Market Report:
Biopharmaceutical Excipients Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
